摘要
马拉色菌。是亲脂性酵母,不仅存在于正常的皮肤微生物群落中,而且还与皮肤相关的疾病(疣状斑疹,脂溢性/特应性皮炎和头皮屑)以及人和动物的系统性真菌感染负责。他们的治疗和根除主要是基于老唑类药物,其特征是依从性差,临床疗效不可预测,出现抗药性和多种副作用。为了提高这种真菌的根除率,这些缺点促使了对单独或组合地靶向其它关键酶/途径(例如碳酸酐酶(MgCA)和脂肪酶)的新型合成和天然衍生物/纳米材料的研究。这项审查完成了关于解决合成脚手架和天然产品的最新发现的重要课题的更新,用于治疗马来西亚相关疾病
关键词: 唑类,碳酸酐酶抑制剂,头皮屑,脂肪酶抑制剂,马拉色氏菌属,天然抑制剂
Current Medicinal Chemistry
Title:Targeting Malassezia species for Novel Synthetic and Natural Antidandruff Agents
Volume: 24 Issue: 22
关键词: 唑类,碳酸酐酶抑制剂,头皮屑,脂肪酶抑制剂,马拉色氏菌属,天然抑制剂
摘要: Malassezia spp. are lipophilic yeasts not only present in the normal skin microflora, but also responsible of skin-related diseases (pityriasis versicolor, seborrheic/atopic dermatitis and dandruff) as well as systemic fungal infections in humans and animals. Their treatment and eradication are mainly based on old azole drugs, which are characterized by poor compliance, unpredictable clinical efficacy, emerging resistance and several side effects. These drawbacks have prompted the research toward novel synthetic and natural derivatives/ nanomaterials targeting other pivotal enzymes/pathways such as carbonic anhydrase (MgCA) and lipases, alone or in combination, in order to improve the eradication rate of this fungus. This review accomplished an update on this important topic dealing with the latest discoveries of synthetic scaffolds and natural products for the treatment of Malasseziaspp.-related diseases, thus suggesting new opportunities to design innovative and alternative anti-dandruff drugs.
Export Options
About this article
Cite this article as:
Targeting Malassezia species for Novel Synthetic and Natural Antidandruff Agents, Current Medicinal Chemistry 2017; 24 (22) . https://dx.doi.org/10.2174/0929867324666170404110631
DOI https://dx.doi.org/10.2174/0929867324666170404110631 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A New Frontier in the Treatment of Cancer: NK-1 Receptor Antagonists
Current Medicinal Chemistry Synthesis and Evaluation of Thiazolidinedione-Coumarin Adducts as Antidiabetic, Anti-Inflammatory and Antioxidant Agents
Letters in Organic Chemistry Message from the Editor-in-Chief
CNS & Neurological Disorders - Drug Targets Patients’ Illness Perceptions of Type 2 Diabetes: A Scoping Review
Current Diabetes Reviews Dual Inhibition of DPP-4 and Cholinesterase Enzymes by the Phytoconstituents of the Ethanolic Extract of Prosopis cineraria Pods: Therapeutic Implications for the Treatment of Diabetes-associated Neurological Impairments
Current Alzheimer Research Chemical Communication-Do We Have a Quorum?
Mini-Reviews in Medicinal Chemistry Histamine H3-Receptor Inverse Agonists as Novel Antipsychotics
Central Nervous System Agents in Medicinal Chemistry Commentary (Research Highlights)
CNS & Neurological Disorders - Drug Targets Liposomes and Micro/Nanoparticles as Colloidal Carriers for Nasal Drug Delivery
Current Drug Delivery Regulation of βAPP and PrPc Cleavage by α-Secretase: Mechanistic and Therapeutic Perspectives
Current Alzheimer Research Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimer's Disease and Mild Cognitive Impairment
Current Alzheimer Research Exploration of Potent Multi-target-directed-ligands as Anti-alzheimer’s Disease Agents: A Moiety Based Review
Mini-Reviews in Medicinal Chemistry Neuroprotective Effects of Intravenous Anesthetics: A New Critical Perspective
Current Pharmaceutical Design Proteome Adjustments Post Gradual Hypoxic Stress in Barilius bendelisis: Insights into Adaptive Strategies of a Hill Stream Cyprinid
Current Proteomics Current Medical and Surgical Stroke Prevention Therapies for Patients with Carotid Artery Stenosis
Current Neurovascular Research Rutin as Neuroprotective Agent: From Bench to Bedside
Current Medicinal Chemistry In Vivo Induced Antigen Technology (IVIAT) and Change Mediated Antigen Technology (CMAT)
Infectious Disorders - Drug Targets A Review of Current Strategies for Treatment Resistant Obsessive-Compulsive Disorder
Current Drug Therapy Analysis of the Fragile X Trinucleotide Repeat in Basques: Association of Premutation and Intermediate Sizes, Anchoring AGGs and Linked Microsatellites with Unstable Alleles
Current Genomics GUT-Brain Axis and Psychiatric Disorders
Current Psychiatry Reviews